Edward Zigler Making preschool available to all children age three and older in the United States would carry great benefits, say three Yale scholars who have won the 2008 University...
Tim Corson Tim Corson, a Yale postdoctoral fellow in the Department of Molecular, Cellular & Developmental Biology, received two top fellowship honors from the Canadian Institutes of Health Research (...
Even though current guidelines advocate colorectal cancer screenings for those with severe illnesses, they may bring little benefit and may actually pose harm, according to a recent study by Yale School of Medicine researchers published in the Archives of...
The largest, most comprehensive study of young women with heart attacks — VIRGO (Variation in Recovery: Role of Gender on Outcomes in Young AMI patients) — was recently launched at Yale School of Medicine with a $9.7 million National Institutes of Health...
Mark Saltzman Bioengineers at Yale and Cornell have created a modified chemotherapy that more effectively reaches and remains at the site of brain tumors — by adding a water-soluble polymer to the anti-...
New Haven, Conn., October 31, 2007 – Yale-New Haven Hospital (YNHH) and Yale University announced today that Yale alumnus Joel E. Smilow (Yale College ’54) will make a major gift to support the new 14-story cancer hospital, currently under construction at...
By using a combination of inexpensive infection control measures, hospitals around the world could prevent half the new cases of extensively drug resistant tuberculosis (XDR TB), according to a new study in The Lancet by researchers at Yale School of...
Drivers aged 70 and older who receive classroom and behind-the-wheel training can significantly improve their driving performance in tests of knowledge and on-road skills, according to a study in the Journal of Gerontology by researchers at Yale School of...
Eugene D. Shapiro, M.D. There is no evidence that “chronic Lyme disease” exists and if it does, the risks of prolonged antibiotic treatment outweigh any benefits, according to a review article by...
David A. Fiellin, M.D. Yale School of Medicine researcher David A. Fiellin, M.D., has received a five-year $2.9 million grant from The National Institutes of Health to advance his research on substance...